Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,686,398
+$485,179 QoQ
Shares Held
1,406
+7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,654
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SBI Okasan Asset Management Co.Ltd. holds $9,003,909 across 7 Drug Manufacturers - General names. LLY ranks #1 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,406 | $1,686,398 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
13,000 | $1,642,420 | |
| 3 | AZN |
Astrazeneca PLC
|
7,025 | $1,332,080 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
22,000 | $1,267,640 | |
| 5 | ABBV |
AbbVie Inc.
|
4,200 | $1,056,888 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,000 | $1,028,000 | |
| 7 | JNJ |
Johnson & Johnson
|
3,900 | $990,483 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,686,398 | 1,406 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,201,219 | 1,306 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,851,673 | 1,723 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||